A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images
A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images

Why limiting AstraZeneca, Johnson & Johnson coronavirus vaccines over blood clot fears could do more harm than good

  • Countries across Europe and the Asia-Pacific have restricted use of both the AstraZeneca and Johnson & Johnson jabs after reports of rare blood clots, despite the risks being minuscule
  • Experts warn this may be an overreaction that could prolong the pandemic by slowing down the roll-out of vaccines and fuelling public hesitancy

Topic |   Coronavirus pandemic
A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images
A health worker prepares a dose of the Johnson & Johnson coronavirus vaccine. Photo: Getty Images
READ FULL ARTICLE